跳至主要内容
临床试验/CTRI/2018/02/012148
CTRI/2018/02/012148招募中2 期

The Role of Fecal Microbiota Transplantation for maintenance of remission in patients with ulcerative colitis

Arshdeep Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Confirmed Ulcerative Colitis patients who are in clinical remission (defined as complete resolution of symptoms) for a minimum duration of 6 months.
  • 2. Patients must be on stable medication regimen for at least 6 months prior to enrollment.
  • 3. Able to give informed consent and/or assent as appropriate

排除标准

  • 1. Patients with active disease
  • 2. Patients having toxic megacolon
  • 3. Treatment naïve patients
  • 4. Pregnant and lactating ladies
  • 5. Prior colectomy
  • 6. Positive stool test for any of the following: Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacter, E. coli by standard stool culture.
  • 7. Regular probiotic supplement use within prior 4 weeks to enrollment
  • 8. Severe immunodeficiency, inherited or acquired (e.g. HIV, chemotherapy, or radiation therapy)
  • 9. Patients unwilling or unable to give consent or participate in all study requirements

研究者

发起方
Arshdeep Singh

相似试验

Stool transplant as treatment in ulcerative colitis | 临床试验